Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021855

Chief R&D Officer bought 7,692 shares at $0.52 ($4,000)

From the SEC's structured data for this filing

Trades in this filing

Cavanagh William · Chief R&D Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-22 Purchase : show line 1 in the form +7,692 $0.52 $4,000 27,692 D
Open-market purchases · 7,692 sh · avg $0.52 · $4,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-22 Purchase : show line 2 in the form Warrant (right to buy) +3,846 705,506 D
Loading xslF345X03/rdgdoc.xml…